XML 16 R6.htm IDEA: XBRL DOCUMENT v3.23.3
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (Unaudited) - USD ($)
$ in Thousands
Common stock
Preferred stock
Nonvested restricted stock
Additional paid-in capital
Accumulated other comprehensive income (loss)
Retained earnings
Total
Beginning balance, value at Dec. 31, 2021 $ 79 $ (1,435) $ 114,226 $ (740) $ 165,771 $ 277,901
Beginning balance shares outstanding at Dec. 31, 2021 7,925,819          
Net income 23,623 23,623
Proceeds from exercise of stock options $ 1 793 794
Proceeds from exercise of stock options (in Shares) 24,750            
Issuance of restricted stock (2,710) 2,710
Issuance of restricted stock (in Shares) 46,775          
Compensation expense related to restricted stock, net of tax 797 797
Compensation expense related to stock options, net of tax 704 704
Other comprehensive loss (13,269) (13,269)
Adoption of ASU 2016-13 (2,765) (2,765)
Ending balance, value at Sep. 30, 2022 $ 80 (3,348) 118,433 (14,009) 186,629 287,785
Ending balance shares outstanding at Sep. 30, 2022 7,997,344          
Beginning balance, value at Jun. 30, 2022 $ 80 (3,230) 117,714 (10,143) 178,216 282,637
Beginning balance shares outstanding at Jun. 30, 2022 7,985,644          
Net income 8,413 8,413
Proceeds from exercise of stock options 87 87
Proceeds from exercise of stock options (in Shares) 3,000          
Issuance of restricted stock (405) 405
Issuance of restricted stock (in Shares) 8,700          
Compensation expense related to restricted stock, net of tax 287 287
Compensation expense related to stock options, net of tax 227 227
Other comprehensive loss (3,866) (3,866)
Ending balance, value at Sep. 30, 2022 $ 80 (3,348) 118,433 (14,009) 186,629 287,785
Ending balance shares outstanding at Sep. 30, 2022 7,997,344          
Beginning balance, value at Dec. 31, 2022 $ 80 (3,306) 119,027 (13,410) 192,121 294,512
Beginning balance shares outstanding at Dec. 31, 2022 8,011,045          
Net income 9,259 9,259
Proceeds from exercise of stock options 497 497
Proceeds from exercise of stock options (in Shares) 25,250            
Issuance of restricted stock $ 1 (1,824) 1,823
Issuance of restricted stock (in Shares) 52,343          
Compensation expense related to restricted stock, net of tax 1,065 1,065
Compensation expense related to stock options, net of tax 410 410
Other comprehensive loss (1,845) (1,845)
Ending balance, value at Sep. 30, 2023 $ 81 (4,065) 121,757 (15,255) 201,380 303,898
Ending balance shares outstanding at Sep. 30, 2023 8,088,638          
Beginning balance, value at Jun. 30, 2023 $ 81 (4,051) 120,912 (12,710) 197,282 301,514
Beginning balance shares outstanding at Jun. 30, 2023 8,058,438          
Net income 4,098 4,098
Proceeds from exercise of stock options 312 312
Proceeds from exercise of stock options (in Shares) 14,250            
Issuance of restricted stock (388) 388
Issuance of restricted stock (in Shares) 15,950          
Compensation expense related to restricted stock, net of tax 374 374
Compensation expense related to stock options, net of tax 145 145
Other comprehensive loss (2,545) (2,545)
Ending balance, value at Sep. 30, 2023 $ 81 $ (4,065) $ 121,757 $ (15,255) $ 201,380 $ 303,898
Ending balance shares outstanding at Sep. 30, 2023 8,088,638